Crossbow Therapeutics, Inc

Crossbow Therapeutics, Inc

生物技术研究

Cambridge,MA 3,833 位关注者

Established antibody engineering to target the untapped universe of intracellular cancer targets, founded by MPM Capital

关于我们

Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt? therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

网站
https://www.crossbowtx.com
所属行业
生物技术研究
规模
11-50 人
总部
Cambridge,MA
类型
私人持股
创立
2021

地点

  • 主要

    1030 Massachusetts Avenue

    Suite 210

    US,MA,Cambridge,02138

    获取路线

Crossbow Therapeutics, Inc员工

动态

相似主页

查看职位

融资